Advance Directives Market by Component (Software, Services), Demographics (Elderly Population (65 yrs & above), Middle Aged (40-64 yrs), Young Adults (18-39 yrs)), End User (B2B (Providers, Payers), B2C), & Region - Global Forecast to 2028
The advance directives market is projected to reach USD 291.1 billion by 2028 from USD 122.9 billion in 2023, at a CAGR of 18.8% during the forecast period. The rising inestments in advance directives and government initiatives and regulations to enhance patient care and autonomy will provide lucrative opportunities to the market during the forecast period.
“Advance directives services segment accounted for a substantial share of the advance directives market, by component in 2022.”
In 2022, the advance directives services segment accounted for a substantial share of the advance directives market. Rising awareness of the importance of proactive healthcare planning, healthcare policies and regulations are increasingly recognizing the benefits of advance directives in terms of reducing unwanted interventions, healthcare costs, and ensuring patient-centered care. This recognition has led healthcare systems to integrate these services into their standard practices, driving the segment's rapid growth.
“Healthcare Providers segment accounted for a considerable share in the advance directives market, by end user in 2022”
In 2022, the healthcare providers segment accounted for a significant share of the advance directives market. As healthcare systems prioritize patient-centered care and personalized treatment, providers play a key role in initiating conversations about end-of-life preferences, treatment options, and medical interventions. Their expertise and trusted relationships with patients position them to effectively navigate sensitive discussions surrounding advance care planning. Moreover, healthcare providers' adoption of electronic health records (EHRs) and digital tools has streamlined the documentation and dissemination of AD documents, enhancing the accessibility and implementation of patient wishes. As a result, the healthcare providers segment stands as a prominent driver of growth within the advance directives market.
“Asia to witness the substantial growth rate during the forecast period.”
The Asian market is projected to grow at the high CAGR during the forecast period due to a confluence of factors that reflect evolving societal attitudes, increased healthcare access, and a growing awareness of patient autonomy. As the region undergoes demographic shifts, including an aging population and an increase in chronic diseases, there is a heightened recognition of the importance of end-of-life planning. Governments and healthcare organizations are working to overcome cultural taboos surrounding discussions of death and end-of-life care, fostering a more open dialogue. Additionally, advancements in healthcare infrastructure and a rise in patient-centered care initiatives are facilitating greater access to AD resources. The desire for patients to have a say in their medical decisions, coupled with efforts to align medical care with individual preferences, is propelling the substantial growth of AD in Asia's forecasted years.
The break-down of primary participants is as mentioned below:
The key players operating in the advance directives market include ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US), Bronson Health Care Group, Inc. (US), Koda Health(US), ThroughCare, Inc.(US), Vital Decisions LLC (US), Affirm Health Inc. (US), MIDEO(US), New Century Health (US), Thanacare(US), Island Health(Canada), Honor My Decisions LLC (US).
Research Coverage:
The report analyzes the Advance directives Market and aims to estimate the market size and future growth potential of various market segments, based on components, demographics , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
“Advance directives services segment accounted for a substantial share of the advance directives market, by component in 2022.”
In 2022, the advance directives services segment accounted for a substantial share of the advance directives market. Rising awareness of the importance of proactive healthcare planning, healthcare policies and regulations are increasingly recognizing the benefits of advance directives in terms of reducing unwanted interventions, healthcare costs, and ensuring patient-centered care. This recognition has led healthcare systems to integrate these services into their standard practices, driving the segment's rapid growth.
“Healthcare Providers segment accounted for a considerable share in the advance directives market, by end user in 2022”
In 2022, the healthcare providers segment accounted for a significant share of the advance directives market. As healthcare systems prioritize patient-centered care and personalized treatment, providers play a key role in initiating conversations about end-of-life preferences, treatment options, and medical interventions. Their expertise and trusted relationships with patients position them to effectively navigate sensitive discussions surrounding advance care planning. Moreover, healthcare providers' adoption of electronic health records (EHRs) and digital tools has streamlined the documentation and dissemination of AD documents, enhancing the accessibility and implementation of patient wishes. As a result, the healthcare providers segment stands as a prominent driver of growth within the advance directives market.
“Asia to witness the substantial growth rate during the forecast period.”
The Asian market is projected to grow at the high CAGR during the forecast period due to a confluence of factors that reflect evolving societal attitudes, increased healthcare access, and a growing awareness of patient autonomy. As the region undergoes demographic shifts, including an aging population and an increase in chronic diseases, there is a heightened recognition of the importance of end-of-life planning. Governments and healthcare organizations are working to overcome cultural taboos surrounding discussions of death and end-of-life care, fostering a more open dialogue. Additionally, advancements in healthcare infrastructure and a rise in patient-centered care initiatives are facilitating greater access to AD resources. The desire for patients to have a say in their medical decisions, coupled with efforts to align medical care with individual preferences, is propelling the substantial growth of AD in Asia's forecasted years.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
- By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%
The key players operating in the advance directives market include ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US), Bronson Health Care Group, Inc. (US), Koda Health(US), ThroughCare, Inc.(US), Vital Decisions LLC (US), Affirm Health Inc. (US), MIDEO(US), New Century Health (US), Thanacare(US), Island Health(Canada), Honor My Decisions LLC (US).
Research Coverage:
The report analyzes the Advance directives Market and aims to estimate the market size and future growth potential of various market segments, based on components, demographics , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (increasing Investments in advance directives in developed as well as emerging technology adoption, rising demand for personalized care, increasing funding and investments in advance care planning, restraints (lack of awareness and education, communication barrier, opportunities (technological advancement and digital solutions, policy support and legislative framework), and challenges (fragmented healthcare system and lack of indiciplinary collaboration and commiunication) influencing the growth of the advance directives market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the advance directives market.
- Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the advance directives market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the advance directives market like ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US) etc.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ADVANCE CARE PLANNING SOLUTIONS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND-SIDE ANALYSIS)
FIGURE 5 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
2.2.2 APPROACH 2: TOP-DOWN OF PARENT MARKET ASSESSMENT
2.2.3 APPROACH 3: PRIMARY INTERVIEWS
2.2.4 APPROACH 4: TOP-DOWN APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: ADVANCE CARE PLANNING SOLUTIONS MARKET
2.8 ADVANCE CARE PLANNING SOLUTIONS MARKET: RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 10 ADVANCE CARE PLANNING SOLUTIONS, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 ADVANCE CARE PLANNING SOLUTIONS, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)
FIGURE 12 ADVANCE CARE PLANNING SOLUTIONS, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 ADVANCE CARE PLANNING SOLUTIONS MARKET OVERVIEW
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER AND COUNTRY (2022)
FIGURE 15 JAPAN TO DOMINATE ASIA PACIFIC MARKET IN 2022
4.3 REGIONAL MIX: ADVANCE CARE PLANNING SOLUTIONS MARKET (2021–2028)
FIGURE 16 ASIA TO REGISTER HIGHEST GROWTH RATE OVER 2023–2028
4.4 ADVANCE CARE PLANNING SOLUTIONS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES, 2023 VS. 2028
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH OVER STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 MARKET DYNAMICS: ADVANCE CARE PLANNING SOLUTIONS MARKET
5.2.1 DRIVERS
5.2.1.1 Rising investments in ACP
5.2.1.2 Government initiatives and regulations to enhance patient care and autonomy
5.2.1.3 Cost-cutting potential of ACP solutions
5.2.1.4 Rising geriatric population and chronic disease prevalence
5.2.2 OPPORTUNITIES
5.2.2.1 Technological advancements and digital solutions
5.2.2.2 Policy support and legislative frameworks
5.2.2.3 Personalized solutions
5.2.3 CHALLENGES
5.2.3.1 Fragmented healthcare systems and integration & cultural challenges
5.2.3.2 Complexity of healthcare systems
5.2.3.3 Lack of interdisciplinary collaboration and communication
5.3 INDUSTRY TRENDS
5.3.1 DIGITAL TRANSFORMATION OF ACP
5.3.2 DATA-DRIVEN INSIGHTS: TRANSFORMING ACP
5.3.3 ENHANCING PATIENT ENGAGEMENT AND PERSONALIZED CARE IN ACP
5.4 TECHNOLOGY ANALYSIS
5.4.1 TECHNOLOGY STACK
5.4.1.1 EHRs and digital platforms
5.4.1.2 Telemedicine/Telehealth
5.4.1.3 Digital access
5.4.1.4 Patient decision support
5.4.1.5 Blockchain technology
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 ADVANCE CARE PLANNING SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF NEW ENTRANTS
5.5.5 THREAT OF SUBSTITUTES
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ADVANCE CARE PLANNING SOLUTIONS MARKET: REGULATORY STANDARDS
5.7 VALUE CHAIN ANALYSIS
FIGURE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET: VALUE CHAIN ANALYSIS (2022)
5.7.1 RESEARCH AND PRODUCT DEVELOPMENT
5.7.2 SERVICE DELIVERY AND IMPLEMENTATION
5.7.3 END-USER INDUSTRIES AND AFTERSALES SERVICE PROVIDERS
5.8 ECOSYSTEM/MARKET MAP
FIGURE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
5.9 PATENT ANALYSIS
FIGURE 21 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO JULY 2023
FIGURE 22 ADVANCE CARE PLANNING SOLUTIONS: TOP PATENT OWNERS
TABLE 8 KEY PATENTS IN ADVANCE CARE PLANNING SOLUTIONS MARKET
5.10 ADJACENT MARKET ANALYSIS
FIGURE 23 CARE MANAGEMENT SOLUTIONS MARKET: MARKET OVERVIEW
FIGURE 24 POPULATION HEALTH MANAGEMENT MARKET: MARKET OVERVIEW
5.11 CASE STUDY ANALYSIS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
5.12.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS
TABLE 10 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS
5.13 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 11 ADVANCE CARE PLANNING SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2023–2024
5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS
FIGURE 27 ADVANCE CARE PLANNING SOLUTIONS: TRENDS/DISRUPTIONS IMPACTING BUYERS
6 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT
6.1 INTRODUCTION
TABLE 12 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
6.2 SOFTWARE
6.2.1 SOFTWARE TO GROW AT HIGHEST CAGR OVER FORECAST PERIOD
TABLE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SERVICES
6.3.1 GROWING AWARENESS OF ACP TO DRIVE DEMAND FOR SERVICES
TABLE 14 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP
7.1 INTRODUCTION
TABLE 15 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
7.2 ELDERLY POPULATION
7.2.1 RISING CHRONIC DISEASE PREVALENCE IN OLDER ADULTS TO DRIVE MARKET
TABLE 16 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR ELDERLY POPULATION, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 MIDDLE-AGED ADULTS
7.3.1 GROWING AWARENESS TO BOOST DEMAND FOR ACP
TABLE 17 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR MIDDLE-AGED ADULTS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 YOUNG ADULTS
7.4.1 RISING RELEVANCE OF ACP AMONG YOUNG ADULTS TO DRIVE DEMAND
TABLE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR YOUNG ADULTS, BY COUNTRY, 2021–2028 (USD MILLION)
8 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 B2B
8.2.1 B2B SEGMENT TO DOMINATE END-USER MARKET
TABLE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 22 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 B2C
8.3.1 B2C END USERS TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
TABLE 24 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR BY B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 26 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR CAREGIVERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
9 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 28 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT
TABLE 29 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 32 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 34 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 US to hold largest share of North American market
TABLE 35 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 36 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 37 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 38 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 39 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Favorable government initiatives to drive market
TABLE 40 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 41 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 42 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 43 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 44 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 45 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to hold largest share of European market
TABLE 51 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 52 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 53 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 54 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising awareness and emphasis on ACP to support market growth
TABLE 56 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 57 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 58 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 59 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3.3 REST OF EUROPE
TABLE 61 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 62 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 63 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 64 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 65 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT
TABLE 66 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 70 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Growing cancer incidence and rising awareness to drive market
TABLE 72 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 73 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 74 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 75 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 China to register highest CAGR over forecast period
TABLE 77 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 78 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 79 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 80 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 81 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4.3 REST OF ASIA PACIFIC
TABLE 82 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 83 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 87 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 88 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 89 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 90 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 30 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS BETWEEN JANUARY 2020 AND AUGUST 2023
10.3 MARKET RANKING ANALYSIS
FIGURE 31 ADVANCE CARE PLANNING SOLUTIONS MARKET RANKING ANALYSIS, BY PLAYER, 2022
10.4 COMPANY EVALUATION MATRIX, 2022
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 32 ADVANCE CARE PLANNING: COMPANY EVALUATION MATRIX (2022)
10.5 COMPETITIVE BENCHMARKING
TABLE 92 ADVANCE CARE PLANNING SOLUTIONS: COMPANY FOOTPRINT ANALYSIS
TABLE 93 COMPONENT FOOTPRINT ANALYSIS (16 COMPANIES)
TABLE 94 END-USER FOOTPRINT ANALYSIS (16 COMPANIES)
10.6 KEY PLAYER ANALYSIS
10.7 COMPETITIVE SCENARIO AND TRENDS
10.7.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 95 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2023
10.7.2 DEALS
TABLE 96 DEALS, JANUARY 2020–AUGUST 2023
10.7.3 OTHER DEVELOPMENTS
TABLE 97 OTHER DEVELOPMENTS, JANUARY 2020– AUGUST 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 ADVAULT, INC.
TABLE 98 ADVAULT, INC.: BUSINESS OVERVIEW
11.1.2 VYNCACARE
TABLE 99 VYNCACARE: BUSINESS OVERVIEW
11.1.3 WISERCARE, INC.
TABLE 100 WISERCARE, INC.: BUSINESS OVERVIEW
11.1.4 IRIS
TABLE 101 IRIS: BUSINESS OVERVIEW
11.1.5 KODA HEALTH
TABLE 102 KODA HEALTH: BUSINESS OVERVIEW
11.1.6 THOROUGHCARE, INC.
TABLE 103 THOROUGHCARE, INC.: BUSINESS OVERVIEW
11.1.7 VITAL DECISIONS LLC
TABLE 104 VITAL DECISIONS LLC: BUSINESS OVERVIEW
11.1.8 AFFIRM HEALTH, INC.
TABLE 105 AFFIRM HEALTH, INC.: BUSINESS OVERVIEW
11.1.9 MIDEO
TABLE 106 MIDEO: BUSINESS OVERVIEW
11.1.10 NEW CENTURY HEALTH
TABLE 107 NEW CENTURY HEALTH: BUSINESS OVERVIEW
11.1.11 THANACARE
TABLE 108 THANACARE: BUSINESS OVERVIEW
11.1.12 HONOR MY DECISIONS LLC
TABLE 109 HONOR MY DECISIONS: BUSINESS OVERVIEW
11.2 NON-PROFIT ORGANIZATIONS
11.2.1 SHARP HEALTHCARE
TABLE 110 SHARP HEALTHCARE: BUSINESS OVERVIEW
11.2.2 ACP DECISIONS
TABLE 111 ACP DECISIONS: BUSINESS OVERVIEW
11.2.3 BRONSON HEALTHCARE
TABLE 112 BRONSON HEALTHCARE: BUSINESS OVERVIEW
11.2.4 ISLAND HEALTH
TABLE 113 ISLAND HEALTH: BUSINESS OVERVIEW
11.2.5 MUNSON HEALTHCARE
TABLE 114 MUNSON HEALTHCARE: BUSINESS OVERVIEW
*Details on Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ADVANCE CARE PLANNING SOLUTIONS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND-SIDE ANALYSIS)
FIGURE 5 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
2.2.2 APPROACH 2: TOP-DOWN OF PARENT MARKET ASSESSMENT
2.2.3 APPROACH 3: PRIMARY INTERVIEWS
2.2.4 APPROACH 4: TOP-DOWN APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: ADVANCE CARE PLANNING SOLUTIONS MARKET
2.8 ADVANCE CARE PLANNING SOLUTIONS MARKET: RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 10 ADVANCE CARE PLANNING SOLUTIONS, BY COMPONENT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 ADVANCE CARE PLANNING SOLUTIONS, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)
FIGURE 12 ADVANCE CARE PLANNING SOLUTIONS, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 ADVANCE CARE PLANNING SOLUTIONS MARKET OVERVIEW
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER AND COUNTRY (2022)
FIGURE 15 JAPAN TO DOMINATE ASIA PACIFIC MARKET IN 2022
4.3 REGIONAL MIX: ADVANCE CARE PLANNING SOLUTIONS MARKET (2021–2028)
FIGURE 16 ASIA TO REGISTER HIGHEST GROWTH RATE OVER 2023–2028
4.4 ADVANCE CARE PLANNING SOLUTIONS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES, 2023 VS. 2028
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH OVER STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 MARKET DYNAMICS: ADVANCE CARE PLANNING SOLUTIONS MARKET
5.2.1 DRIVERS
5.2.1.1 Rising investments in ACP
5.2.1.2 Government initiatives and regulations to enhance patient care and autonomy
5.2.1.3 Cost-cutting potential of ACP solutions
5.2.1.4 Rising geriatric population and chronic disease prevalence
5.2.2 OPPORTUNITIES
5.2.2.1 Technological advancements and digital solutions
5.2.2.2 Policy support and legislative frameworks
5.2.2.3 Personalized solutions
5.2.3 CHALLENGES
5.2.3.1 Fragmented healthcare systems and integration & cultural challenges
5.2.3.2 Complexity of healthcare systems
5.2.3.3 Lack of interdisciplinary collaboration and communication
5.3 INDUSTRY TRENDS
5.3.1 DIGITAL TRANSFORMATION OF ACP
5.3.2 DATA-DRIVEN INSIGHTS: TRANSFORMING ACP
5.3.3 ENHANCING PATIENT ENGAGEMENT AND PERSONALIZED CARE IN ACP
5.4 TECHNOLOGY ANALYSIS
5.4.1 TECHNOLOGY STACK
5.4.1.1 EHRs and digital platforms
5.4.1.2 Telemedicine/Telehealth
5.4.1.3 Digital access
5.4.1.4 Patient decision support
5.4.1.5 Blockchain technology
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 ADVANCE CARE PLANNING SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF NEW ENTRANTS
5.5.5 THREAT OF SUBSTITUTES
5.6 REGULATORY LANDSCAPE
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ADVANCE CARE PLANNING SOLUTIONS MARKET: REGULATORY STANDARDS
5.7 VALUE CHAIN ANALYSIS
FIGURE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET: VALUE CHAIN ANALYSIS (2022)
5.7.1 RESEARCH AND PRODUCT DEVELOPMENT
5.7.2 SERVICE DELIVERY AND IMPLEMENTATION
5.7.3 END-USER INDUSTRIES AND AFTERSALES SERVICE PROVIDERS
5.8 ECOSYSTEM/MARKET MAP
FIGURE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
5.9 PATENT ANALYSIS
FIGURE 21 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO JULY 2023
FIGURE 22 ADVANCE CARE PLANNING SOLUTIONS: TOP PATENT OWNERS
TABLE 8 KEY PATENTS IN ADVANCE CARE PLANNING SOLUTIONS MARKET
5.10 ADJACENT MARKET ANALYSIS
FIGURE 23 CARE MANAGEMENT SOLUTIONS MARKET: MARKET OVERVIEW
FIGURE 24 POPULATION HEALTH MANAGEMENT MARKET: MARKET OVERVIEW
5.11 CASE STUDY ANALYSIS
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
5.12.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS
TABLE 10 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS
5.13 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 11 ADVANCE CARE PLANNING SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2023–2024
5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS
FIGURE 27 ADVANCE CARE PLANNING SOLUTIONS: TRENDS/DISRUPTIONS IMPACTING BUYERS
6 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT
6.1 INTRODUCTION
TABLE 12 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
6.2 SOFTWARE
6.2.1 SOFTWARE TO GROW AT HIGHEST CAGR OVER FORECAST PERIOD
TABLE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SERVICES
6.3.1 GROWING AWARENESS OF ACP TO DRIVE DEMAND FOR SERVICES
TABLE 14 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP
7.1 INTRODUCTION
TABLE 15 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
7.2 ELDERLY POPULATION
7.2.1 RISING CHRONIC DISEASE PREVALENCE IN OLDER ADULTS TO DRIVE MARKET
TABLE 16 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR ELDERLY POPULATION, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 MIDDLE-AGED ADULTS
7.3.1 GROWING AWARENESS TO BOOST DEMAND FOR ACP
TABLE 17 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR MIDDLE-AGED ADULTS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 YOUNG ADULTS
7.4.1 RISING RELEVANCE OF ACP AMONG YOUNG ADULTS TO DRIVE DEMAND
TABLE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR YOUNG ADULTS, BY COUNTRY, 2021–2028 (USD MILLION)
8 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 B2B
8.2.1 B2B SEGMENT TO DOMINATE END-USER MARKET
TABLE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 22 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 23 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 B2C
8.3.1 B2C END USERS TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD
TABLE 24 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR BY B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 26 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR CAREGIVERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
9 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 28 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT
TABLE 29 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 31 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 32 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 34 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 US to hold largest share of North American market
TABLE 35 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 36 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 37 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 38 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 39 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Favorable government initiatives to drive market
TABLE 40 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 41 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 42 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 43 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 44 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 45 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 48 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to hold largest share of European market
TABLE 51 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 52 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 53 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 54 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising awareness and emphasis on ACP to support market growth
TABLE 56 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 57 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 58 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 59 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.3.3 REST OF EUROPE
TABLE 61 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 62 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 63 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 64 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 65 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT
TABLE 66 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 70 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Growing cancer incidence and rising awareness to drive market
TABLE 72 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 73 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 74 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 75 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 China to register highest CAGR over forecast period
TABLE 77 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 78 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 79 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 80 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 81 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.4.3 REST OF ASIA PACIFIC
TABLE 82 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 83 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 84 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 87 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
TABLE 88 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION)
TABLE 89 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
TABLE 90 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 30 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS BETWEEN JANUARY 2020 AND AUGUST 2023
10.3 MARKET RANKING ANALYSIS
FIGURE 31 ADVANCE CARE PLANNING SOLUTIONS MARKET RANKING ANALYSIS, BY PLAYER, 2022
10.4 COMPANY EVALUATION MATRIX, 2022
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 32 ADVANCE CARE PLANNING: COMPANY EVALUATION MATRIX (2022)
10.5 COMPETITIVE BENCHMARKING
TABLE 92 ADVANCE CARE PLANNING SOLUTIONS: COMPANY FOOTPRINT ANALYSIS
TABLE 93 COMPONENT FOOTPRINT ANALYSIS (16 COMPANIES)
TABLE 94 END-USER FOOTPRINT ANALYSIS (16 COMPANIES)
10.6 KEY PLAYER ANALYSIS
10.7 COMPETITIVE SCENARIO AND TRENDS
10.7.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 95 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2023
10.7.2 DEALS
TABLE 96 DEALS, JANUARY 2020–AUGUST 2023
10.7.3 OTHER DEVELOPMENTS
TABLE 97 OTHER DEVELOPMENTS, JANUARY 2020– AUGUST 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 ADVAULT, INC.
TABLE 98 ADVAULT, INC.: BUSINESS OVERVIEW
11.1.2 VYNCACARE
TABLE 99 VYNCACARE: BUSINESS OVERVIEW
11.1.3 WISERCARE, INC.
TABLE 100 WISERCARE, INC.: BUSINESS OVERVIEW
11.1.4 IRIS
TABLE 101 IRIS: BUSINESS OVERVIEW
11.1.5 KODA HEALTH
TABLE 102 KODA HEALTH: BUSINESS OVERVIEW
11.1.6 THOROUGHCARE, INC.
TABLE 103 THOROUGHCARE, INC.: BUSINESS OVERVIEW
11.1.7 VITAL DECISIONS LLC
TABLE 104 VITAL DECISIONS LLC: BUSINESS OVERVIEW
11.1.8 AFFIRM HEALTH, INC.
TABLE 105 AFFIRM HEALTH, INC.: BUSINESS OVERVIEW
11.1.9 MIDEO
TABLE 106 MIDEO: BUSINESS OVERVIEW
11.1.10 NEW CENTURY HEALTH
TABLE 107 NEW CENTURY HEALTH: BUSINESS OVERVIEW
11.1.11 THANACARE
TABLE 108 THANACARE: BUSINESS OVERVIEW
11.1.12 HONOR MY DECISIONS LLC
TABLE 109 HONOR MY DECISIONS: BUSINESS OVERVIEW
11.2 NON-PROFIT ORGANIZATIONS
11.2.1 SHARP HEALTHCARE
TABLE 110 SHARP HEALTHCARE: BUSINESS OVERVIEW
11.2.2 ACP DECISIONS
TABLE 111 ACP DECISIONS: BUSINESS OVERVIEW
11.2.3 BRONSON HEALTHCARE
TABLE 112 BRONSON HEALTHCARE: BUSINESS OVERVIEW
11.2.4 ISLAND HEALTH
TABLE 113 ISLAND HEALTH: BUSINESS OVERVIEW
11.2.5 MUNSON HEALTHCARE
TABLE 114 MUNSON HEALTHCARE: BUSINESS OVERVIEW
*Details on Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
